Iryna Saranchova
Net worth: - $ as of 2026-09-29
Net worth: - $ as of 2026-09-29
Iryna Saranchova is currently Chief Clinical Officer at MYND Life Sciences, Inc. since 2021 and Chief Science Officer at Voyageur Pharmaceuticals Ltd. since 2024.
The education history includes a doctorate from the University of British Columbia and a graduate degree from Lviv University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-03 | 0 ( -.--% ) | - $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| VOYAGEUR PHARMACEUTICALS LTD. | Chief Tech/Sci/R&D Officer | 2024-09-16 |
| Companies | Position | End |
|---|---|---|
| MYND LIFE SCIENCES INC. | Chief Tech/Sci/R&D Officer | 2024-07-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lviv University
Lviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Ltd. Chemicals: AgriculturalProcess Industries Engages in exploring and development of barite, iodine and fullerene | Process Industries |
MYND Life Sciences, Inc.
MYND Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions